Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 11545 

PPR serves as the primary basis for 

ACL’s monitoring activities in 

fulfillment of its responsibilities under 

sections 706 and 722 of the Act. ACL 

also uses the PPR to identify training 

and technical assistance needs for SILCs 

and centers for independent living. 

To view the data collection activity 

for this information collection request, 

please visit the ACL public input 

website: https://www.acl.gov/about-acl/ 

public-input. 

Comments in Response to the 60-Day 

Federal Register Notice 

ACL published a 60-day Federal 

Register Notice in the Federal Register 

soliciting public comments on this 

request. The 60-day FRN published on 

December 17, 2020, Volume 85, pages 

81924–81925; ACL received no 

comments. 

Estimated Program Burden 

ACL estimates the burden of this 

collection of information as follows: 

Fifty-six jurisdictions—specifically, the 

fifty states, Puerto Rico, the District of 

Columbia, American Samoa, the 

Commonwealth of the Northern Mariana 

Islands, Guam, and the US Virgin 

Islands—will each complete ILS PPRs 

annually, and it will take an estimated 

thirty-five hours per jurisdiction per ILS 

PPR. Each jurisdiction’s SILC and DSE 

will collaborate to complete the ILS 

PPR. The fifty-six jurisdictions, 

combined, will take an estimated 1,960 

hours per year to complete ILS PPRs. 

This burden estimate is based on what 

DSEs and SILCs have told ACL about 

how long filling out ILS PPRs took in 

previous reporting years. 

Respondent/data collection activity Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response 

Total annual 

burden hours 

SILCs and DSEs .............................................................................................. 56 1 35 1,960 

Dated: February 19, 2021. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2021–03864 Filed 2–24–21; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

[OMB N0. 0985–0048] 

Agency Information Collection 

Activities; Proposed Collection; Public 

Comment Request; State Grants for 

Assistive Technology Program State 

Plan for Assistive Technology 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

an opportunity for the public to 

comment on the proposed collection of 

information listed above. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish a notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

renewal of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the Proposed Extension without Change 

on the information collection 

requirements related to the State Grants 

for Assistive Technology Program State 

Plan for AT. 

DATES: Comments on the collection of 

information must be submitted 

electronically by 11:59 p.m. (EST) or 

postmarked by April 26, 2021. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to: Robert Groenendaal, 

Robert.Groenendaal@acl.hhs.gov. 

Submit written comments on the 

collection of information to the 

Administration for Community Living 

330 C Street SW, Washington, DC 

20201. Attention: Robert Groenendaal. 

FOR FURTHER INFORMATION CONTACT: 

Robert Groenendaal, Assistive 

Technology Program Manager, Center 

for Innovation and Partnership in the 

Office of Interagency Innovation 

Administration for Community Living 

330 C Street SW, Washington, DC 

20201, Phone: 202–795–7356, Email: 

Robert.Groenendaal@acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA, Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information,’’ is defined 

as and includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. 

The PRA requires Federal agencies to 

provide a 60-day notice in the Federal 

Register concerning each proposed 

collection of information, including 

each proposed extension of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, ACL is publishing a notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, ACL invites 

comments on our burden estimates or 

any other aspect of this collection of 

information, including: 

(1) Whether the proposed collection 

of information is necessary for the 

proper performance of ACL’s functions, 

including whether the information will 

have practical utility; 

(2) the accuracy of ACL’s estimate of 

the burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used 

to determine burden estimates; 

(3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and 

(4) ways to minimize the burden of 

the collection of information on 

respondents, including through the use 

of automated collection techniques 

when appropriate, and other forms of 

information technology. 

The information collected through 

this data collection instrument is 

necessary for ACL and states to comply 

with Sections 4 and 7 of the Assistive 

Technology Act of 1998, as amended 

(AT Act). ACL is requesting a revision 

of the state plan data collection 

instrument (OMB No. 0985–0048). 

Approval of 0985–0048 expires March 

31, 2021. 

Section 4 of the AT Act authorizes 

grants to public agencies in the 50 states 

and the District of Columbia, Puerto 

Rico, the Virgin Islands, Guam, 

American Samoa, and the 

Commonwealth of the Northern 

Marianas (states and outlying areas). 

With these funds, the 56 states and 

outlying areas operate ‘‘Statewide AT 

Programs’’ that conduct activities to 

increase access to and acquisition of 

assistive technology (AT) for 

individuals with disabilities and older 

Americans. 

11546 Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 

Divided into two comprehensive 

activity categories: ‘‘State-level 

Activities’’ and ‘‘State Leadership 

Activities,’’ according to Section 4 of the 

AT Act, as a condition of receiving a 

grant to support their Statewide AT 

Programs, the 56 states and outlying 

areas must provide to ACL: (1) 

Applications and (2) annual progress 

reports on their activities. 

Applications: The application 

required of states and outlying areas is 

a three-year State Plan for Assistive 

Technology (State Plan for AT or State 

Plan) (OMB No. 0985–0048). The 

content of the State Plan for AT is based 

on the requirements in Section 4(d) of 

the AT Act. 

Annual Reports: In addition to 

submitting a State Plan, every three 

years, states and outlying areas are 

required to submit annual progress 

reports on their activities. The data 

required in that progress report is 

specified in Section 4(f) of the AT Act 

(OMB No. 0985–0042). 

National aggregation of data related to 

measurable goals is necessary for the 

Government Performance and Results 

Modernization Act of 2010 (GPRAMA) 

(Pub. L. 111–352), as well as an Annual 

Report to Congress (see ‘‘Section 7 

Requirements Necessitating Collection’’ 

below). Therefore, this data collection 

instrument provides a way for all 56 

grantees—50 U.S. states, DC, Puerto 

Rico, the U.S. Virgin Islands, Guam, 

American Samoa, and the 

Commonwealth of the Northern Mariana 

Islands to collect and report data on 

their activities in a consistent manner, 

including a uniform survey to be given 

to consumers. This uniform survey is 

included as part of the data collection 

package. 

Section 7(d) of the AT Act requires 

that ACL submit to Congress an annual 

report on the activities conducted under 

the Act and an analysis of the progress 

of the states and outlying areas in 

meeting their measurable goals. This 

report must include a compilation and 

summary of the data collected under 

Section 4(f). In order to make this 

possible, states and outlying areas must 

provide their data uniformly. This data 

collection instrument was developed to 

ensure that all 56 states and outlying 

areas report data in a consistent manner 

in alignment with the requirements of 

Section 4(f). 

As stated above, ACL will use the 

information collected via this 

instrument to: 

(1) Complete the annual report to 

Congress required by the AT Act; 

(2) Comply with reporting 

requirements under the Government 

Performance and Results Modernization 

Act of 2010 (GPRAMA) (Pub. L. 111– 

352); and 

(3) Assess the progress of states and 

outlying areas regarding measurable 

goals. Data collected from the grantees 

will provide a national description of 

activities funded under the AT Act to 

increase the access to and acquisition of 

AT devices and services through 

statewide AT programs for individuals 

with disabilities. Data collected from 

grantees will also provide information 

for usage by Congress, the Department, 

and the public. In addition, ACL will 

use this data to inform program 

management, monitoring, and technical 

assistance efforts. States will be able to 

use the data for internal management 

and program improvement. 

To review the proposed data 

collection tools please visit the ACL 

website at: https://www.acl.gov/aboutacl/public-input. 

Estimated Program Burden: ACL 

estimates the burden associated with 

this collection of information as follows: 

Respondent/data collection activity Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response 

Annual burden 

hours 

State Plan for Assistive Technology ................................................................ 56 1 73.0 4,088 

Dated: February 19, 2021. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2021–03868 Filed 2–24–21; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The invention listed below is 

owned by an agency of the U.S. 

Government and is available for 

licensing to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

FOR FURTHER INFORMATION CONTACT: 

Peter Soukas, J.D., 301–594–8730; 

peter.soukas@nih.gov. Licensing 

information and copies of the patent 

applications listed below may be 

obtained by communicating with the 

indicated licensing contact at the 

Technology Transfer and Intellectual 

Property Office, National Institute of 

Allergy and Infectious Diseases, 5601 

Fishers Lane, Rockville, MD 20852; tel. 

301–496–2644. A signed Confidential 

Disclosure Agreement will be required 

to receive copies of unpublished patent 

applications. 

SUPPLEMENTARY INFORMATION: 

Technology description follows. 

Improved Live-Attenuated Vaccine for 

Respiratory Syncytial Virus (RSV) 

Bearing Codon-Pair Deoptimized NS1, 

NS2, N, P, M and SH Genes and 

Additional Point Mutations in the P 

Gene 

Description of Technology: 

RSV is the most important viral agent 

of severe respiratory disease in infants 

and young children worldwide and also 

causes substantial morbidity and 

mortality in older adults. RSV is 

estimated to cause more than 33 million 

lower respiratory tract illnesses, three 

million hospitalizations, and nearly 

200,000 childhood deaths worldwide 

annually, with many deaths occurring 

in developing countries. However, 

despite the prevalence of RSV and the 

dangers associated with infection, no 

RSV vaccine has been successfully 

developed to date. Accordingly, there is 

a public health need for RSV vaccines. 

This vaccine candidate comprises live 

RSV that was attenuated by subjecting 

the protein-coding sequences of the 

viral NS1, NS2, N, P, M, and SH genes 

to codon-pair deoptimization, which 

resulted in many nucleotide 

substitutions that were silent at the 

amino acid level but conferred 

attenuation. In addition, specific amino 

acid substitutions were identified and 

introduced into the P protein that 

improved attenuation and genetic 

stability. Genetic stability was 

confirmed in vitro, and attenuation was 

confirmed in experimental animals.